propranolol has been researched along with Telangiectasis in 6 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Telangiectasis: Permanent dilation of preexisting blood vessels (CAPILLARIES; ARTERIOLES; VENULES) creating small focal red lesions, most commonly in the skin or mucous membranes. It is characterized by the prominence of skin blood vessels, such as vascular spiders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol is an approved non-selective β-adrenergic blocker that is first line therapy for infantile hemangioma." | 7.91 | R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma. ( Andelfinger, G; Bischoff, J; Chiang, IK; Fontaine, F; Francois, M; Gambin, Y; Hamdan, M; Huang, L; Khosrotehrani, K; Lesieur, E; Meurer, M; Moustaqil, M; Overman, J; Pasquier, E; Patel, J; Sierecki, E; Wylie-Sears, J; Zuegg, J, 2019) |
| "Propranolol is an approved non-selective β-adrenergic blocker that is first line therapy for infantile hemangioma." | 3.91 | R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma. ( Andelfinger, G; Bischoff, J; Chiang, IK; Fontaine, F; Francois, M; Gambin, Y; Hamdan, M; Huang, L; Khosrotehrani, K; Lesieur, E; Meurer, M; Moustaqil, M; Overman, J; Pasquier, E; Patel, J; Sierecki, E; Wylie-Sears, J; Zuegg, J, 2019) |
| "Infantile hemangiomas are well known for their rapid growth during the first 6 to 9 months of life, followed by a spontaneous but slow involution." | 1.42 | Diode laser for the treatment of telangiectasias following hemangioma involution. ( Cerrati, EW; Chung, H; O, TM; Waner, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peuvrel, L | 1 |
| Bregeon, B | 1 |
| Saint-Jean, M | 1 |
| Quéreux, G | 1 |
| Frénard, C | 1 |
| Khammari, A | 1 |
| Wdowik, A | 1 |
| Dréno, B | 1 |
| Babic, V | 1 |
| Schoeffler, A | 1 |
| Moawad, S | 1 |
| Mainard, L | 1 |
| Schmutz, JL | 1 |
| Bursztejn, AC | 1 |
| Yu, Z | 1 |
| Cai, R | 1 |
| Chang, L | 1 |
| Qiu, Y | 1 |
| Chen, X | 1 |
| Chen, Q | 1 |
| Ma, G | 1 |
| Jin, Y | 1 |
| Lin, X | 1 |
| Overman, J | 1 |
| Fontaine, F | 1 |
| Wylie-Sears, J | 1 |
| Moustaqil, M | 1 |
| Huang, L | 1 |
| Meurer, M | 1 |
| Chiang, IK | 1 |
| Lesieur, E | 1 |
| Patel, J | 1 |
| Zuegg, J | 1 |
| Pasquier, E | 1 |
| Sierecki, E | 1 |
| Gambin, Y | 1 |
| Hamdan, M | 1 |
| Khosrotehrani, K | 1 |
| Andelfinger, G | 1 |
| Bischoff, J | 1 |
| Francois, M | 1 |
| Cerrati, EW | 1 |
| O, TM | 1 |
| Chung, H | 1 |
| Waner, M | 1 |
| Seiler, G | 1 |
| Mehmel, HC | 1 |
| Krayenbühl, HP | 1 |
1 review available for propranolol and Telangiectasis
| Article | Year |
|---|---|
[Rare presentations of infantile hemangiomas: 4 cases].
Topics: Biopsy; Buttocks; Delayed Diagnosis; Erythema; Facial Neoplasms; Female; Foot Diseases; Hemangioma, | 2018 |
5 other studies available for propranolol and Telangiectasis
| Article | Year |
|---|---|
First case of trastuzumab emtansine-associated hemorrhagic telangiectasias treated with propranolol.
Topics: Ado-Trastuzumab Emtansine; Adrenergic beta-Antagonists; Antineoplastic Agents, Immunological; Female | 2019 |
Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
Topics: Administration, Oral; Child, Preschool; Disease Progression; Erythema; Female; Follow-Up Studies; He | 2019 |
R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma.
Topics: Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Enzyme Inhibitors; Hemangioma; Humans; | 2019 |
Diode laser for the treatment of telangiectasias following hemangioma involution.
Topics: Child; Child, Preschool; Female; Hemangioma; Humans; Infant; Lasers, Semiconductor; Male; Propranolo | 2015 |
[Isometric load before and after autonomic-nervous blockade with propranolol and atropine].
Topics: Adult; Atropine; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiovascular System; Fem | 1974 |